A citation-based method for searching scientific literature

F John Service. Diabetes 2013
Times Cited: 116



Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina, Gaetano Frajese, Simona Frontoni. Diabetes Care 2011
Times Cited: 109




List of shared articles



Times cited

Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study.
Yumie Takeshita, Takeo Tanaka, Hitomi Wakakuri, Yuki Kita, Takehiro Kanamori, Toshinari Takamura. J Diabetes Investig 2021
0

Glycemic variability and cardiovascular disease in patients with type 2 diabetes.
Marcela Martinez, Jimena Santamarina, Adrian Pavesi, Carla Musso, Guillermo E Umpierrez. BMJ Open Diabetes Res Care 2021
0

Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study.
Maria Isabel Del Olmo-García, David Hervás Marín, Jana Caudet Esteban, Antonio Ballesteros Martin-Portugués, Alba Cerveró Rubio, Miguel Angel Arnau Vives, Ana Catalá Gregori, Maite Penalba Martínez, Juan Francisco Merino-Torres. J Int Med Res 2020
0

Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association?
Szabolcs Nyiraty, Fruzsina Pesei, Andrea Orosz, Sara Coluzzi, Orsolya Eszter Vági, Csaba Lengyel, György Ábrahám, Simona Frontoni, Peter Kempler, Tamás Várkonyi. Front Endocrinol (Lausanne) 2018
11

Glycemic variability in the development of cardiovascular complications in diabetes.
Annunziata Nusca, Dario Tuccinardi, Marzia Albano, Camilla Cavallaro, Elisabetta Ricottini, Silvia Manfrini, Paolo Pozzilli, Germano Di Sciascio. Diabetes Metab Res Rev 2018
46

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.
Guillermo E Umpierrez, Boris P Kovatchev. Am J Med Sci 2018
26


Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
Boris Kovatchev, Guillermo Umpierrez, Andres DiGenio, Rong Zhou, Silvio E Inzucchi. J Diabetes Sci Technol 2015
9